Abstract
32
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful 33
model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from 34
healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods 35
produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of 36
maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC 37
donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of 38
iPSC-CM electrophysiology have been developed to help understand the ionic underpinnings of, and to 39
simulate, various cell responses, but these models individually do not capture the phenotypic variability 40
observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate 41
cell preparation-specific iPSC-CM electrophysiological parameters. 42
We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters 43
in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that 44
generates sufficient data for parameter calibration, we created simulated datasets by applying various 45
protocols to a population of in silico cells with known conductance variations, and we fitted to those datasets. 46
We found that calibrating models to voltage and calcium transient data under 3 varied experimental conditions, 47
including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, 48
improved model parameter estimates and model predictions of unseen channel block responses. This 49
observation held regardless of whether the fitted data were normalized, suggesting that normalized 50
fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could 51
sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different 52
iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms 53
behind variability in perturbation responses. 54
55
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
3
Author Summary: 56
Many drug treatments or environmental factors can trigger cardiac arrhythmias, which are dangerous and often 57
unpredictable. Human cardiomyocytes derived from donor stem cells have proven to be a promising model for 58
studying these events, but variability in donor genetic background and cell maturation methods, as well as 59
overall immaturity of stem cell-derived cardiomyocytes relative to the adult heart, have hindered reproducibility 60
and reliability of these studies. Mathematical models of these cells can aid in understanding the underlying 61
electrophysiological contributors to this variability, but determining these models’ parameters for multiple cell 62
preparations is challenging. In this study, we tackle these limitations by developing a computational method to 63
simultaneously estimate multiple model parameters using data from imaging-based experiments, which can be 64
easily scaled to rapidly characterize multiple cell lines. This method can generate many personalized models of 65
individual cell preparations, improving drug response predictions and revealing specific differences in 66
electrophysiological properties that contribute to variability in cardiac maturity and arrhythmia susceptibility.67
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
4
ABBREVIATIONS 68
AP: Action potential 69
CaT: Calcium transient 70
GA: Genetic algorithm 71
Gx, Ix, Jx: Maximal conductance (G), current density (I), or flux (J) for x, where x can be: Na (Na+), f 72
(funny Na+), CaL (L-type Ca2+), to (transient outward K+), Ks (slow delayed rectifier K+), Kr (rapid 73
delayed rectifier K+), K1 (inward rectifier K+), PMCA (plasma membrane Ca2+ ATPase), bNa 74
(background Na+), bCa (background Ca2+), Up (SR Ca2+ uptake), rel (SR Ca2+ release), NCX (Na+/Ca2+ 75
exchanger), NaK (Na+/K+ ATPase), SRleak (SR leak), or CaT (T-type Ca2+) 76
iPSC-CM: Induced pluripotent stem cell-derived cardiomyocyte 77
LTCC: L-type calcium channel 78
NCX: Sodium-calcium exchanger 79
SERCA: Sarco/endoplasmic reticulum calcium ATPase 80
SR: Sarcoplasmic reticulum 81
82
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
5
GLOSSARY 83
Model/parameter calibration: tuning one or more parameters in the computational model so that the 84
model output more closely matches experimental data 85
Experiment/protocol optimization: the process of determining what type and amount of data is 86
sufficient but also feasible for our model calibration goals 87
o Protocol conditions – buffer calcium, potassium, or sodium concentrations; addition or removal 88
of stimulus; pacing rates; channel block; etc. 89
o Protocol length(?) – number of protocol conditions 90
o Protocol data type(?) –AP, CaT, or both; normalized or non-normalized data 91
Model prediction: using the calibrated computational model to simulate response to new (unseen) 92
conditions, drugs, or perturbations (in our case, IKr block) 93
o Papers on independent validation/prediction 94
Computational pipeline: the full process of iPSC-CM computational model calibration; Includes iPSC-CM 95
data acquisition/simulation -> data processing -> parameter calibration using genetic algorithm -> validation of 96
calibrated models on an unseen condition (i.e. evaluating model predictions) 97
98
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
6
Introduction
99
Human iPSC-derived cardiomyocytes (iPSC-CMs) are derived from patient cells that have been reprogrammed 100
into pluripotency and subsequently manipulated to differentiate into the cardiac cell lineage. The development 101
of this in vitro platform marked a technological breakthrough in cardiac research, and iPSC-CMs are now 102
widely-used in cardiac pharmacology and disease research. iPSCs can be sourced through minimally-invasive 103
procedures, such as skin biopsy or blood draw, and maintained or banked for long periods [1,2]. These 104
properties of iPSC-CMs make them an ideal platform for pharmacological studies and personalized disease 105
modeling [3]. However, electrophysiological variability between iPSC-CM preparations from different cell lines 106
and differentiation methods limit the potential of this platform [4,5]. 107
Mathematical models of cardiomyocyte electrophysiology can provide valuable insight into iPSC-CM 108
electrophysiological variability. These models contain parameters describing the ionic currents and fluxes that 109
contribute to the properties of cardiac action potential (AP) and calcium transient (CaT) waveforms. Several 110
models of iPSC-CM physiology exist in the literature [6–8], with the most recent and comprehensive model 111
published by Kernik et al. in 2019, hereon referred to as the “Kernik model” [9]. However, the baseline 112
parameter values in these models are not representative of the electrophysiological heterogeneity observed in 113
iPSC-CMs. Additionally, parameter calibration has often relied on separate patch clamp measurements of each 114
type of current. This process is time-consuming, inaccessible to many research groups, and often captures the 115
physiology of only the average behavior of the population of cells examined. Methods to simultaneously 116
optimize several or all model parameters using minimal data are under development [10–14]. Recent work on 117
guinea pig ventricular myocyte models [13] and human iPSC-CM models [14] have demonstrated the utility of 118
automated tuning algorithms for improving model parameterization. For example, in Devenyi et al [13], an 119
adjusted model, constrained by data, predicted the effect of slow delayed rectifier K+ current (IKs) block more 120
accurately compared to baseline model. Analogous work, at the level of individual ion channels, has shown the 121
superiority of sinusoidal voltage clamp protocols, compared with traditional square-wave protocols, for 122
calibration of channel kinetic parameters [15]. 123
Even with recent advances in iPSC-CM maturation protocols [16–19], most iPSC-CMs still display embryonic- 124
or neonatal-like cardiac phenotypes with different AP and CaT shapes compared with adult myocytes. These 125
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
7
phenotypic differences, and how they change temporally, can depend on subtle differences in cell culture 126
conditions and the genetic background of the cell donor [4,5,20], which likely contributes to the wide variation 127
observed between studies [4,5]. No standardized procedure currently exists for characterizing iPSC-CM 128
heterogeneity; prior efforts have generally examined a handful of molecular markers [21], used subjective 129
observations of physiology [22,23], or employed specialized methods such as single cell RNA sequencing 130
[24,25]. These factors, and the potential importance of iPSC-CMs as a research platform, highlight the need for 131
automated methods to characterize the cell lines used in each study. 132
Here we combined these ideas of simultaneous calibration of multiple parameters and optimization of a 133
minimal experimental protocol for generating calibration data. We aimed to create digital twins of iPSC-CM cell 134
preparations from the Kernik iPSC-CM model, thereby connecting observed iPSC-CM electrophysiology with 135
molecular function and mechanisms. We hypothesize that fluorescence readouts of iPSC-CM physiology under 136
varied experimental conditions provide enough information to reveal cellular ion channel properties, which can 137
then be incorporated into the iPSC-CM digital twins. To systematically evaluate various data types and 138
experimental protocols in their ability to inform model parameters, we created a simulated, in silico dataset 139
from Kernik model variations with known parameter values. From this study, we developed a computational 140
pipeline which includes: 1) an optimized protocol for fluorescence recordings of iPSC-CM preparations; 2) a 141
genetic algorithm process for calibration of ion channel parameters in iPSC-CM computational model, using 142
the experimental recordings; and 3) validation of the resulting calibrated models by evaluating their predictions 143
on independent, yet physiologically-important, perturbations. We demonstrate the utility of our computational 144
pipeline in generating iPSC-CM digital twins that capture ionic variability and predict cell-specific 145
electrophysiological phenotypes, including drug-induced arrhythmia susceptibility. 146
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
8
Results
147
Our primary objective was to optimize an experimental protocol for generating sufficient data to calibrate an 148
iPSC-CM mathematical model, taking experimental feasibility and throughput into account. To systematically 149
evaluate how different types of data and experimental conditions impact parameter calibration and model 150
predictions of responses to new conditions or drug treatments, we created a simulated in silico dataset, 151
generated from a population of Kernik models with random variations in their 16 maximal conductance 152
parameters (Figure 1A, Supplementary Table S2). We simulated AP and CaT generated by these model cells 153
under various conditions (Supplementary Table S3), and then concatenated these data in various 154
combinations based on the “candidate protocols” we wanted to evaluate. The 16 Kernik model conductance 155
parameters were then calibrated, using a genetic algorithm, to best match the steady state AP and CaT traces 156
from each candidate protocol. These fitted parameters were incorporated into the Kernik model, and the newly-157
calibrated models were evaluated on their ability to predict the original model cell’s responses to new 158
conditions (outlined in methods and Figure 1B). Optimizing the experimental protocol using this in silico dataset 159
provided 3 major advantages: 1) knowledge of the ground truth parameter values that generated the dataset, 160
so the accuracy of the calibrated parameters can be evaluated, 2) relatively fast and easy simulation of new 161
conditions from the same or additional model cells, in comparison to acquiring new in vitro data and cell lines, 162
and 3) generating corresponding data types through computational methods and data processing, forgoing the 163
need to set up new experiments to collect each data type. 164
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
9
165
Simultaneously calibrating to AP and CaT data improves model predictions 166
First, we examined whether AP or CaT recordings alone provided sufficient information for conductance 167
parameter calibration and model predictions. We used simulated recordings from baseline physiological 168
conditions without pacing stimuli (spontaneous APs), and supplied to a genetic algorithm (GA) either 1) only 169
the AP traces, 2) only the CaT traces, or 3) both (Figure 2A). The GA calibrates parameters by varying them to 170
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
10
create a population of Kernik model cells, then iteratively selecting and modifying individual models that 171
generated AP and CaT traces that best matched the supplied data (outlined in Figure 1B ) [26]. We ran the 172
genetic algorithm 10 times per input dataset, with each GA run starting on a different initial population of 173
models. This allowed us to assess whether each input dataset provided enough information to consistently 174
estimate parameter values, even when the initial search space varied. 175
176
We evaluated each candidate protocol on parameter calibration accuracy (calibration error) and consistency 177
(calibration spread). Calibration error was represented by the absolute values of calibrated value log-178
normalized to the corresponding ground truth parameter value, and calibration spread was assessed by 179
calculating the standard deviation (spread) in log-normalized calibrated parameter values between the 10 runs 180
(Figure 2B). After averaging over all 16 fitted parameters, we found minimal differences in calibration error (p = 181
0.11) or spread (p = 0.07) between fitting only voltage, only calcium, or both simultaneously ( Figure 2C). From 182
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
11
these initial tests, therefore, there appears to be little difference between experimental protocols in how well (or 183
poorly) each can identify model parameters. 184
We next assessed the calibrated models from each candidate protocol on how well each predicted model cell 185
responses to 30% block of rapid delayed rectifier current IKr,as this perturbation is both: 1) independent of the 186
conditions used for model calibration and 2) relevant to cardiac pharmacology [27]. With this evaluation (Figure 187
3A), we found that models fitted to only AP data or only CaT data differed significantly from the ground truth 188
model (Figure 3B, Supplementary Figure S1). When both AP and CaT recordings were used simultaneously 189
during parameter calibration, the resulting calibrated models exhibited substantial improvement in their 190
predictions of 30% IKr block. Therefore, fitting parameters to both AP and CaT traces simultaneously is 191
required for accurate prediction of results that were not used in the fitting process. 192
193
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
12
Overall parameter error and spread show minimal change with varied protocol conditions 194
Next, we explored how varying the number and identity of simulated conditions in the candidate protocols 195
affected parameter calibration. AP and CaT recordings were simulated under many conditions that could be 196
produced in an electrophysiology laboratory and constructed candidate protocols from various combinations of 197
these conditions, which included: 1) varied buffer calcium, from hypo- to normal to hyper-calcemic conditions, 198
2) spontaneous beating and varied pacing rates from 1-2 Hz, 3) varied levels of L-type calcium channel (ICaL) 199
blockade, and 4) a mixture of these conditions (see Methods for details). We also separated these data into 200
shorter protocols, to see if the experimental setup could be further simplified (Figure 4A). Unexpectedly, we 201
found that parameter errors and spread across all 16 maximal conductance parameters did not differ 202
significantly between the protocols with varied cell culture conditions (Figure 4B, p = 0.814 and p = 0.673, 203
respectively). Additionally, we observed no significant differences in average calibration errors (p = 0.088) and 204
spreads (p = 0.137) when varying the number of conditions in the protocol (Figure 4C). Similar findings were 205
observed when evaluating different combinations of these experimental conditions (Supplementary Figure S2). 206
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
13
207
A readily-achievable 3-condition protocol improves predictions of IKr block response 208
As with the results shown in Figure 3, we assessed how well calibrated models predicted the response to IKr 209
block, and we found that accuracy depended strongly on the experimental conditions simulated in each 210
candidate protocol (sample AP traces shown in Figure 5A). Out of the protocols using 3 experimental 211
conditions in Figure 4A, the mixed-conditions protocol generated calibrated models with the most accurate 212
predictions of changes in APs with 30% IKr block, compared with protocols which varied only the buffer 213
calcium, pacing rates, or ICaL blockade (Figure 5B-C). When evaluating whether a shorter version of this 214
protocol could produce equally predictive models, the full protocol with all 3 conditions outperformed protocols 215
with 1 or 2 of the conditions (Figure 5B-C). These data suggest that an optimal experimental protocol for iPSC-216
CM model parameter calibration should include voltage and calcium transient fluorescence recordings under at 217
least 3 varieties of cell culture condition changes or perturbations. Of note, this supports our hypothesis that 218
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
14
data from iPSC-CMs under a variety of conditions provides sufficient parameter identification to generate 219
predictive models for pharmacological applications. 220
221
Normalized fluorescence recordings sufficiently inform parameter calibration 222
Fluorescence recordings generally detect relative changes and do not provide absolute levels of voltage and 223
calcium. Fluorescent dyes can be calibrated [28,29], and patch clamp can detect true transmembrane 224
potentials, but these are more challenging and lower-throughput techniques, compared with straightforward 225
fluorescence recordings. To assess the potential implications for parameter identification, we compared two 226
versions of simulated recordings obtained with our optimized protocol: 1) unscaled (original) in silico data, 227
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
15
representing patch clamp and calibrated calcium measurements, and 2) normalized versions of the same 228
waveforms, representing simpler fluorescent recordings (Figure 6A). 229
230
Parameter calibration accuracy and consistency did not differ significantly when comparing calibrated models 231
from the original data with those from the corresponding normalized data (Figure 6B). Notably, calibrated 232
models from these two data types also performed similarly when evaluating predictions of 30% I Kr block 233
response (Figure 6C). This suggests that fluorescence voltage and calcium recordings from our optimized 234
protocol conditions provide sufficient information to calibrate predictive models. 235
Calibrated models predict variability in arrhythmia susceptibility in silico 236
The primary goal of optimizing a computational pipeline for model calibration is to create cell preparation-237
specific models that can predict variability in phenotypes, particularly arrhythmia susceptibility, between iPSC-238
CM lines. To assess the ability of our optimized protocol to predict cell line-specific arrhythmia susceptibility, 239
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
16
we calculated the lowest level of IKr block (i.e. highest % IKr) that induced arrhythmia dynamics 240
(afterdepolarizations, Torsades de Pointes, alternans, beating cessation, or tachycardia) in the same 4 Kernik 241
model cells from our in silico dataset. These simulations defined, for each of the 4 model cells, an “IKr block 242
tolerance threshold” (Figure 7A), which ranged from 37% IKr block (highest susceptibility) to 62% IKr block 243
(highest tolerance) (Figure 7C) across the 4 model cells. 244
245
Predicted IKr block tolerance thresholds were also calculated for the calibrated models generated by our 246
computational pipeline. These predicted thresholds were assessed against the ground truth threshold of the 247
model cell. Calibrated models from our computational pipeline predicted IKr block thresholds with high accuracy 248
and consistency, with similar error and spread as models calibrated to corresponding non-normalized 249
recordings (Figure 7B). The aggregated calibrated models also predicted relative arrhythmia susceptibility of 250
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
17
the 4 model cells, as shown by a significant positive correlation between ground truth and predicted IKr block 251
thresholds in Figure 7C. Additionally, there was no correlation between the model cell’s true IKr block threshold 252
and its associated calibrated models’ prediction error, suggesting that the accuracy of these predictions would 253
not be affected by variability in arrhythmia susceptibility between iPSC-CM preparations (Figure 7D). 254
Optimized model calibration process constrains key ionic parameters 255
Throughout the protocol optimization process, we observed that while calibration error and spread largely 256
remained constant when averaged over all fitted parameters, certain individual parameters consistently 257
showed low calibration spread (e.g. GKr, GNaK) or high calibration spread (e.g. Grel, GCaT) (Supplementary 258
Figure S3). Thus, we hypothesized that our calibration method only needs to tightly constrain a few key 259
parameters, tolerating inaccuracy or variation in less important parameters while still generating highly 260
predictive calibrated models. To determine whether normalized data from the optimized protocol constrains the 261
parameters that play the largest roles in determining AP and CaT morphology, we analyzed the relationship 262
between parameter calibration accuracy and consistency with the Kernik model’s sensitivity to parameter 263
changes. We used multivariable regression to determine how the 16 calibrated model parameters affect 264
relevant phenotypes such as AP duration, CaT amplitude, and IKr block threshold (Figure 8A) [30]. The 265
resulting model coefficients represent the magnitude and direction of the effect of changes in the 266
corresponding parameter on the modeled phenotype (Figure 8A-C). The most important parameters depended 267
on which model output was considered (Figure 8A-C), but parameters that appeared frequently included rapid 268
delayed rectifier K+ conductance (GKr), L-type Ca2+ conductance (GCaL), Na+ conductance (GNa), inward rectifier 269
K+ conductance (GK1), and Na+/K+ pump conductance (GNaK). 270
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
18
271
We then grouped the parameters into the highest and lowest regression coefficient magnitudes for each 272
phenotype, and assessed calibration errors and calibration spreads from the optimized calibration protocol 273
within those groups. The 4 parameters with highest regression coefficient magnitudes for CaT amplitude and 274
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
19
IKr block threshold showed significantly lower average calibration error and spread compared with the 4 275
parameters with the lowest regression coefficient magnitudes (Figure 8E-F). Accordingly, the optimized 276
calibration protocol displayed significant improvement over most other candidate protocols in predictions of 277
CaT amplitude and IKr block threshold. We saw similar results when examining calibration errors and spreads 278
in parameters grouped by APD90 sensitivity, though the difference in calibration errors was not statistically 279
significant (Figure 8D). These results suggest that our optimized computational pipeline does constrain the key 280
Kernik model conductance parameters needed to generate predictive models. 281
Validation of optimized computational pipeline on in vitro iPSC-CM recordings 282
After optimization of our computational pipeline using in silico data, where the ground truth model parameter 283
values were known, we assessed whether our pipeline could still generate predictive models using in vitro 284
data. We applied the computational pipeline to normalized fluorescence AP and CaT recordings from one 285
iPSC-CM cell line under different combinations of 3 varied conditions: 1) low buffer calcium (1.0 mM) with 1 Hz 286
pacing, 2) physiological buffer calcium (1.8 mM) with 1 Hz pacing, and 3) physiological buffer calcium with 1.25 287
Hz pacing. Figure 9A outlines the data processing and normalization procedures performed on the 288
fluorescence recordings prior to model calibration. Recordings from a separate condition (1.0 mM buffer 289
calcium with 2 Hz pacing) were left out from model calibration, so they could be used to independently 290
evaluate predictions generated by the calibrated model. 291
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
20
292
Calibrating the model conductances using data from only one of these conditions resulted in unconstrained 293
conductance values and highly variable predictions of response to the left-out validation data (Figure 9B). 294
Including data from 2 additional, mixed conditions significantly improved consistency of key conductance 295
parameter calibrations (Figure 9C). When these calibrated parameters were incorporated into the Kernik model 296
and the cell line’s response to a new condition was predicted, we found that models calibrated to recordings 297
from 3 conditions substantially outperformed models calibrated to only 1 condition. These results further 298
supported our findings from in silico protocol optimization, showing that data from fluorescence voltage and 299
calcium transients under 3 varied conditions can constrain key model parameters and generate predictive, cell 300
preparation-specific models. 301
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
21
Discussion
302
While the application of iPSC-derived cardiomyocytes to cardiac disease and pharmacology research has 303
grown dramatically in the past decade, intrinsic and extrinsic variability between cell preparations still hinders 304
reproducibility and clinical translation of studies that use these cells. Generic out-of-box mathematical models 305
of iPSC-CMs do not reflect this variability and potentially generate inaccurate predictions when used to 306
simulate pharmacological ion channel effects or genetic variations [10]. In this study, we aimed to overcome 307
these limitations of the iPSC-CM in vitro platform and their mathematical models by creating a computational 308
pipeline which can rapidly identify the cell preparation-specific ionic properties contributing to this phenotypic 309
variability. The parameter calibration algorithm we used, a heuristic genetic algorithm, allows for selection of 310
specific parameters of interest or parameter value limits, and is suitable for parallel computing. To determine 311
the feasibility of this approach, we used a model-generated in silico dataset to evaluate candidate protocols 312
containing varied data types and experimental conditions. We found an optimized protocol for fluorescence AP 313
and CaT recordings, consisting of varied buffer calcium concentration, electrical pacing, and ICaL block 314
conditions, which provided enough information to calibrate accurate and predictive cell-specific models, while 315
remaining short in duration and straightforward to acquire. Subsequent model calibrations with an in vitro 316
dataset suggested potential flexibility in which specific conditions are selected for the protocol. In our 317
computational pipeline development and subsequent validation, these data were able to inform key ionic 318
contributors, generating calibrated models which accurately and consistently predicted cell-specific responses 319
to IKr block. 320
Calibration of models of cardiac electrophysiology 321
Parameter values in computational models of cardiac electrophysiology are often determined by manual fits to 322
voltage and current recordings, often collected under one or few experimental conditions. This limits the 323
baseline models’ ability to represent electrophysiological heterogeneity. Additionally, determination of these 324
baseline parameter values may be affected by selection bias for cells with larger currents, inadequate 325
separation of activation and inactivation kinetics, and inter-laboratory differences in current and voltage clamp 326
protocols [31]. These issues have, in many cases, led researchers to recalibrate the model parameters in 327
attempts to better reflect the behaviors of their specific cardiomyocyte preparations. For example, Potse et al. 328
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
22
fitted a reaction-diffusion model of ventricular electrical activity to reproduce phenotypes of patients with heart 329
failure or left branch bundle block [32]. Similarly, Lombardo et al. tuned atrial electrophysiology models for 330
patients undergoing ablation therapy [33] whereas Krogh-Madsen et al. used the genetic algorithm to fit a 331
human ventricular cardiac model to clinical QT interval data [34]. In all three cases, these groups found 332
significant discrepancies between the respective initial models and their final, calibrated, fit-for-purpose 333
models. However, to the best of our knowledge, the experimental data used in virtually all previous 334
cardiomyocyte model calibration research come from voltage clamp, patch clamp, or clinical data. Currently, 335
these data are still difficult to obtain from a large group of patients or cell preparations. More recent work has 336
demonstrated the utility of genetic algorithms and the resulting recalibrated models in prediction of arrhythmic 337
behaviors and drug mechanisms, but these also used complex voltage step protocols to calibrate model 338
parameters [35]. These prior results motivated our search for protocols that could calibrate mathematical 339
models using voltage- and calcium-sensitive fluorescent dye measurements, which are considerably easier to 340
acquire than patch-clamp recordings. 341
Guiding experimental design for optimal parameter calibration 342
We considered several factors when optimizing the experimental protocol to generate iPSC-CM data for our 343
computational pipeline: 1) the information that the data would provide for parameter calibration, 2) the 344
complexity of the protocol, and 3) the feasibility of the experiment for broad accessibility and high throughput 345
setups. Since the goal of model calibration is usually to improve the accuracy of model parameterizations and 346
predictions, previous work has largely focused on designing experiments to maximize the information content 347
of the resulting data [36–38]. In particular, for cardiac electrophysiology models, model calibration has almost 348
universally been performed on data from complex voltage step protocols, in order to accurately determine 349
individual ion channel conductances and kinetics [10,39,40]. Here, we emphasize that it is also important to 350
identify adaptable protocols that can be widely adopted. Therefore, we opted to focus on using fluorescence 351
recordings to calibrate model parameters, instead of the usual techniques such as patch clamp. To evaluate 352
different protocols, we created an in silico dataset for testing various data combinations in their ability to inform 353
parameter calibration. This approach provided 2 major advantages. First, guided by experimental feasibility 354
and relevance, we were able to simulate iPSC-CM electrophysiology under many combinations of conditions 355
without the time and financial costs associated with in vitro experiments. Second, we knew the ground truth 356
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
23
ionic parameter values that produced these AP and CaT traces, so we could precisely assess which simulated 357
conditions informed which parameters. We also ran multiple rounds of genetic algorithms on each tested in 358
silico protocol, with each round starting from a different initial model population, to assess how consistently 359
each parameter was identified. We used this as a measure of confidence in each parameter estimate. 360
In their analysis on model parameter constraint using regression and Bayesian approaches, Sarkar and Sobie 361
found that, in both cases, parameter constraint improved when values for more than one output feature were 362
provided [41]. Similarly, we found that calibrating model parameters to fluorescence recordings of AP and CaT 363
traces, as opposed to using only one of the two, resulted in better parameter constraint for some (but not all) 364
parameters. Perhaps more importantly, we found that calibrating to both outputs simultaneously resulted in 365
significant improvement of the calibrated models’ predictions on a new, independent output. This is consistent 366
with prior results which showed that, when translating drug responses across cell types, using multiple 367
electrophysiological features or observations of iPSC-CMs under multiple conditions improved translations 368
[42–44]. Similarly, our final optimized protocol included a mixture of 3 experimental conditions. Finally, overall 369
parameter calibration accuracy and consistency, as well as independent predictions of IKr block response, were 370
similar between the models fitted to normalized data (representing fluorescence data) and those fitted to 371
corresponding non-normalized data (representing patch clamp and calibrated Ca2+ transient data). Collectively, 372
these findings support our hypothesis that data from fluorescence recordings under multiple conditions, which 373
are more practical compared with microelectrode or patch clamp recordings, can be used to calibrate 374
predictive models. Notably, several parameters such as the background Ca2+ and Na+ conductances, GKs, and 375
Grel were rarely constrained by any of the datasets we tested. Our subsequent parameter sensitivity analysis 376
showed that model conductances that strongly affect relevant model outputs tend to be well-constrained by our 377
optimized protocol. 378
Prediction of cell-specific arrhythmia susceptibility 379
Finally, we demonstrated that our optimized computational pipeline can generate consistent and predictive 380
mathematical models from in vitro iPSC-CM data, using fluorescence voltage and calcium recordings under a 381
similar set of experimental conditions. Many therapeutics have the potential to induce patient-specific 382
arrhythmic effects through their intended targets (e.g. quinidine blockade of INa and IKr) or unintended effects 383
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
24
(e.g. antibiotic off-target blockade of K+ channels) [45,46]. Previous analyses of systems biology models have 384
also argued the importance of a prediction-focused computational modeling approach. In an influential paper, 385
Gutenkunst et al. posited that a model that accurately predicts relevant phenotypes even with some parameter 386
value inaccuracies is more useful than a model with high parameter accuracy and consistency, but inaccurate 387
predictions [47]. This suggests that attempting to determine parameter values directly through precise 388
measurements is an inefficient way of optimizing models. Subsequent studies in both cell signaling and cardiac 389
electrophysiology models have demonstrated success in focusing parameter calibrations on optimizing 390
prediction accuracy in place of specific parameter accuracy [11,48,49]. These analyses demonstrate the 391
importance of calibrating models to not only fit available experimental data, but also generate accurate 392
predictions of responses to novel perturbations. 393
Therefore, while optimizing the computational pipeline, we included a prediction metric in addition to parameter 394
value accuracy and consistency. We created a quantifiable, pharmacologically-relevant measure of cell-395
specific arrhythmia susceptibility by finding the lowest level of IKr block that induced arrhythmic dynamics in 396
each Kernik model (in silico) or iPSC-CM preparation (in vitro), which we termed the “IKr block tolerance 397
threshold”. Calibrated models from our optimized computational pipeline were able to predict this threshold 398
consistently and accurately, with similar error as those from calibrating to the original, non-normalized data. 399
The models calibrated to normalized data were also able to correctly rank the IKr block arrhythmia 400
susceptibilities of the fitted Kernik model cells, suggesting that the models generated by this pipeline contain 401
enough information to predict cell-specific arrhythmia susceptibilities, despite errors and non-constraint of 402
several smaller conductance parameters. 403
Limitations
and potential directions 404
The model calibration process developed and optimized in this study can be applied broadly to research that 405
investigates the ionic mechanisms behind iPSC-CM phenotype variability or predicts differential effects of 406
therapeutics on various iPSC-CM cell lines and preparations. However, phenotypic variability also exists within 407
iPSC-CMs from the same preparation. While it is possible to use fluorescent dyes to record electrophysiology 408
of individual cells, we currently focused our efforts on calibrating models to represent multicellular preparations. 409
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
25
Future work could include adapting this computational pipeline to calibrate models representing single 410
cardiomyocytes within an iPSC-CM preparation. 411
Several conductance parameters fitted in our current pipeline did not contribute significantly to 412
electrophysiological phenotype and responses (e.g. Gf, GSRleak, and Grel), according to our parameter sensitivity 413
analyses. Many of these same parameters were also less accurate and less constrained by our computational 414
pipeline. While we showed that the resulting calibrated models could accurately predict several major 415
electrophysiology phenotypes and channel block responses, we do not know whether these models could still 416
predict responses that are strongly affected by one or more of the unconstrained parameters. Calibrated 417
models generated by our computational pipeline should be evaluated on their ability to predict cell-specific 418
susceptibility to other pro- or anti-arrhythmia triggers of interest, such as ICaL or buffer [K+] changes. If 419
improving parameter calibration accuracy and constraint of particular ionic current(s) is found to be necessary 420
for model predictive power, one option would be to replace the conductances with lowest parameter sensitivity 421
regression coefficient magnitudes with representative kinetic parameters, such as time constants or activation 422
gates. If these kinetic parameters are found to impact electrophysiology in a manner that is detectable by the 423
genetic algorithm, their calibrations will likely be more accurate and constrained, generating more precise cell 424
preparation-specific iPSC-CM models. 425
Conclusions
426
The optimized model calibration computational pipeline we developed in this study can be applied to ongoing 427
pharmacological and disease studies to understand cell response variability in iPSC-CMs and advance 428
precision medicine. Our pipeline simultaneously fits multiple model parameters to fluorescence voltage and 429
calcium recordings, which are quicker and simpler to acquire than the patch clamp or other more involved 430
electrophysiological techniques used in prior model calibration work. The ability to use fluorescence recordings 431
increases this pipeline’s accessibility and throughput compared to prior methods. This unique characteristic 432
makes our computational pipeline suitable for rapid generation of cell-specific models for therapeutic, disease, 433
or population studies. Comparing cell-specific model parameters between iPSC-CM cell lines or to a 434
benchmark, such as an adult cardiac model, would reveal ionic mechanisms behind this variability in iPSC-CM 435
maturation and phenotypes. In addition, the personalized models created by this computational pipeline can 436
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
26
simulate patient-specific drug and perturbation responses to quickly predict therapeutic efficacy or drug 437
cardiotoxicity. In future studies, these calibrated iPSC-CM models can inform translation of ionic properties and 438
physiological responses into adult cardiac models, which could, in turn, generate even more accurate, 439
clinically-relevant cardiac electrophysiology phenotype and drug response predictions. 440
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
27
Methods
441
Simulations of iPSC-CM electrophysiology 442
In silico simulations of iPSC-CM electrophysiology (e.g. membrane potential, calcium transients, changes in 443
maximal conductances and ionic currents) were carried out in MATLAB R2020b by solving the ordinary 444
differential equations defined in the Kernik et al. (2019) mathematical model of human iPSC-CMs [9], using the 445
initial conditions listed in Supplementary Table S1. In cases where a protocol included cardiomyocyte pacing, 446
electrical stimuli of 60 pA/pF were simulated for a duration of 1 ms at the specified intervals. All simulations 447
were run for 5 minutes, which was sufficient to achieve a steady state using the baseline model and 448
physiological, unperturbed conditions (Supplementary Table S3, protocol #19). The voltage and intracellular 449
calcium concentration from the final 5 seconds of each simulation were stored and included in the in silico 450
dataset. 451
In silico dataset for optimization of iPSC-CM experimental protocol 452
To simulate a heterogeneous set of iPSC-CM cell lines, a “population” of Kernik model cells was created by 453
drawing multiplier factors for each maximal conductance parameter from a log-normal distribution with mean 454
multiplier = 1, spread = 0.2. This population was then simulated under physiological, unperturbed conditions 455
(Supplementary Table S3, protocol 19), and filtered for cells which showed a spontaneous beating frequency 456
between 0.3 Hz and 1.0 Hz, nearly matching the automaticity rate range for human iPSC-CMs reported in [50]. 457
Out of the remaining model cells, 4 were randomly selected for simulation under the 19 different conditions, to 458
generate the final in silico dataset. The Kernik model’s baseline conductance parameter values and the scaled 459
conductances for these 4 model cells are listed in Supplementary Table S2. A list of the various conditions 460
these 4 cells were simulated under can be found in Supplementary Table S3. All simulations were run for a 5-461
minute time span (steady state under physiological buffer conditions, without pacing), and membrane potential 462
and intracellular calcium recordings from the final 5 seconds of these simulations were extracted and stored for 463
the in silico dataset. The built-in interp1 function in MATLAB was used to interpolate these data in equal time 464
steps (0.1 ms). To mimic processed data from fluorescence recordings, we also created “normalized” versions 465
of each dataset by scaling the data from a minimum of 0 to a maximum of 1. This dataset allowed for 466
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
28
comparison of conductance parameter estimates produced during model calibration against known ground 467
truth conductance values. 468
Parameter calibration using the genetic algorithm 469
The data used for calibrating model parameters included the steady state AP and CaT waves from the 470
previously-generated in silico dataset. Individual simulation runs are either included or excluded from the fitting 471
procedure to compare different experimental “candidate protocols”. Rapid delayed rectifier potassium current 472
(IKr) block conditions were left out from protocol optimization to use for conductance estimate validation. If the 473
candidate protocol consists of more than 1 condition, the final values of membrane potential, intracellular 474
calcium concentration, and other steady state parameters are used as the starting values for the subsequent 475
protocol condition. To determine the optimal protocol for accurate and consistent parameter identification, 476
Kernik model maximal conductance parameters were fitted to in silico from each candidate protocol simulated 477
for 4 of the dataset’s model cells, using the genetic algorithm (GA) [10,12]. Briefly, the GA creates a new 478
population of Kernik model cells, each randomly assigned a set of conductance parameter scale factors, and 479
simulates the candidate protocol for each of these model cells. Then, the mean squared error between 480
corresponding data points in the GA-generated trace and the trace from the in silico dataset is calculated. The 481
model cells with the lowest errors are retained, while higher-scoring cells have their parameter values altered 482
in the next algorithm iteration. Details about specific GA settings, such as population size and parameter 483
retention/alteration criteria, can be found in Supplementary Table S4. This process repeats for 20 iterations, 484
where each new population has a lower average error than the previous. The parameters of the model cell with 485
the lowest error from the final population are selected as the final calibrated parameter values from that run. 486
Parameter calibrations are conducted 10 times per candidate protocol per model cell, with each of the 10 GA 487
runs starting with a different set of initial model populations. The 10 sets of conductance estimates from each 488
GA run are evaluated on 1) accuracy to the ground truth parameter values of the model cells and 2) ability to 489
predict the model cell’s response to a perturbation that was not seen during parameter calibration, such as IKr 490
block. 491
In vitro iPSC-CM tissue culture and optical recordings 492
Human induced pluripotent stem cells (iPSCs) derived from a single cell line were differentiated into 493
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
29
cardiomyocytes (iPSC-CMs) by modulating canonical Wnt signaling [51]. The cardiomyocytes were enriched, 494
then combined with cardiac fibroblasts in a ratio of 90% iPSC-CMs to 10% fibroblasts within a collagen-fibrin 495
hydrogel solution (InvivoSciences, Inc., Madison, WI, USA). The engineered heart tissues (EHTs) thus formed 496
were maintained in a serum-free cardiac maintenance medium, supplemented with penicillin and streptomycin 497
(Thermo Fisher Scientific, Waltham, MA, USA), within 96-well micro culture plates (MC-96, InvivoSciences). 498
EHT maintenance was carried out as previously described in relevant literature [52]. Following a five-day 499
remodeling phase, the EHTs underwent further maturation with biphasic constant current electrical stimulations 500
at a frequency of 1Hz for 8 days. 501
For optical voltage and calcium transient recordings, the EHTs were loaded with Fluovolt (at a dilution of 1:500, 502
Thermo Fisher Scientific), or Cal-520 AM (also at 1:500, AAT Bioquest), along with PowerLoad (Thermo Fisher 503
Scientific), by incubating them for one hour in Tyrode’s solution. This solution was prepared with either 1.0 mM 504
or 1.8 mM [Ca2+]. Following the removal of the dyes, the solution was pH adjusted to 7.4 and warmed, and 505
Tyrode’s solution with the corresponding calcium concentration was reintroduced to aid in recovery from dye 506
loading stress over a 30-minute period. The EHTs were then paced at frequencies of 1.0 Hz, 1.25 Hz, or 2.0 507
Hz for five minutes. The steady-state membrane potential and intracellular calcium transients during this period 508
were recorded using a high-throughput fluorescence plate imager, FDSS/µCell (Hamamatsu Photonics K.K., 509
Japan), utilizing 470nm excitation and 540nm emission at a rate of 125 data points per second. The collected 510
data were analyzed with the iVSurfer™ software (InvivoSciences), specifically designed for high-throughput 511
waveform data analysis. 512
Processing of in vitro iPSC-CM recordings for the computational pipeline 513
Fluorescence voltage and calcium recordings were processed in MATLAB with baseline drift subtraction 514
(imerode function), median filtering to remove noise (medfilt1 function), and the same normalization steps as 515
the pseudo-data. Kernik model maximal conductance parameters were fitted to these data using the same 516
workflow as prior fittings to pseudo-data, with the 1.0mM buffer [Ca2+], 2.0Hz pacing data left out for validation.517
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
30
References
518
1. Karakikes I, Ameen M, Termglinchan V, Wu JC. Human Induced Pluripotent Stem Cell-Derived 519
Cardiomyocytes: Insights into Molecular, Cellular, and Functional Phenotypes. Circ Res. 2015;117: 80–88. 520
doi:10.1161/CIRCRESAHA.117.305365 521
2. Huang C-Y, Liu C-L, Ting C-Y, Chiu Y-T, Cheng Y-C, Nicholson MW, et al. Human iPSC banking: barriers 522
and opportunities. J Biomed Sci. 2019;26: 87. doi:10.1186/s12929-019-0578-x 523
3. Hnatiuk AP, Briganti F, Staudt DW, Mercola M. Human iPSC modeling of heart disease for drug 524
development. Cell Chem Biol. 2021;28: 271–282. doi:10.1016/j.chembiol.2021.02.016 525
4. Yang J, Argenziano MA, Burgos Angulo M, Bertalovitz A, Beidokhti MN, McDonald TV. Phenotypic 526
Variability in iPSC-Induced Cardiomyocytes and Cardiac Fibroblasts Carrying Diverse LMNA Mutations. 527
Front Physiol. 2021;12: 778982. doi:10.3389/fphys.2021.778982 528
5. Nakagawa M, Ooie T, Ou B, Ichinose M, Takahashi N, Hara M, et al. Gender differences in autonomic 529
modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol. 2005;16: 278–284. 530
doi:10.1046/j.1540-8167.2005.40455.x 531
6. Paci M, Hyttinen J, Aalto-Setälä K, Severi S. Computational models of ventricular- and atrial-like human 532
induced pluripotent stem cell derived cardiomyocytes. Ann Biomed Eng. 2013;41: 2334–2348. 533
doi:10.1007/s10439-013-0833-3 534
7. Koivumäki JT, Naumenko N, Tuomainen T, Takalo J, Oksanen M, Puttonen KA, et al. Structural Immaturity 535
of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease 536
Modeling. Front Physiol. 2018;9: 80. doi:10.3389/fphys.2018.00080 537
8. Paci M, Pölönen R-P, Cori D, Penttinen K, Aalto-Setälä K, Severi S, et al. Automatic Optimization of an in 538
Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities. 539
Front Physiol. 2018;9: 709. doi:10.3389/fphys.2018.00709 540
9. Kernik DC, Morotti S, Wu H, Garg P, Duff HJ, Kurokawa J, et al. A computational model of induced 541
pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data 542
sources. J Physiol. 2019;597: 4533–4564. doi:10.1113/JP277724 543
10. Groenendaal W, Ortega FA, Kherlopian AR, Zygmunt AC, Krogh-Madsen T, Christini DJ. Cell-Specific 544
Cardiac Electrophysiology Models. PLoS Comput Biol. 2015;11: e1004242. 545
doi:10.1371/journal.pcbi.1004242 546
11. Dokos S, Lovell NH. Parameter estimation in cardiac ionic models. Prog Biophys Mol Biol. 2004;85: 407–547
431. doi:10.1016/j.pbiomolbio.2004.02.002 548
12. Syed Z, Vigmond E, Nattel S, Leon LJ. Atrial cell action potential parameter fitting using genetic algorithms. 549
Med Biol Eng Comput. 2005;43: 561–571. doi:10.1007/BF02351029 550
13. Devenyi RA, Ortega FA, Groenendaal W, Krogh-Madsen T, Christini DJ, Sobie EA. Differential roles of two 551
delayed rectifier potassium currents in regulation of ventricular action potential duration and arrhythmia 552
susceptibility. J Physiol. 2017;595: 2301–2317. doi:10.1113/JP273191 553
14. Akwaboah AD, Tsevi B, Yamlome P, Treat JA, Brucal-Hallare M, Cordeiro JM, et al. An in silico hiPSC-554
Derived Cardiomyocyte Model Built With Genetic Algorithm. Front Physiol. 2021;12: 675867. 555
doi:10.3389/fphys.2021.675867 556
15. Beattie KA, Hill AP, Bardenet R, Cui Y, Vandenberg JI, Gavaghan DJ, et al. Sinusoidal voltage protocols 557
for rapid characterisation of ion channel kinetics. J Physiol. 2018;596: 1813–1828. doi:10.1113/JP275733 558
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
31
16. Ahmed RE, Anzai T, Chanthra N, Uosaki H. A Brief Review of Current Maturation Methods for Human 559
Induced Pluripotent Stem Cells-Derived Cardiomyocytes. Front Cell Dev Biol. 2020;8. Available: 560
https://www.frontiersin.org/article/10.3389/fcell.2020.00178 561
17. Karbassi E, Fenix A, Marchiano S, Muraoka N, Nakamura K, Yang X, et al. Cardiomyocyte maturation: 562
advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol. 2020;17: 341–359. 563
doi:10.1038/s41569-019-0331-x 564
18. James EC, Tomaskovic-Crook E, Crook JM. Bioengineering Clinically Relevant Cardiomyocytes and 565
Cardiac Tissues from Pluripotent Stem Cells. Int J Mol Sci. 2021;22: 3005. doi:10.3390/ijms22063005 566
19. Guo Y, Pu W. Cardiomyocyte Maturation: New Phase in Development. Circ Res. 2020;126: 1086–1106. 567
doi:10.1161/CIRCRESAHA.119.315862 568
20. Mannhardt I, Saleem U, Mosqueira D, Loos MF, Ulmer BM, Lemoine MD, et al. Comparison of 10 Control 569
hPSC Lines for Drug Screening in an Engineered Heart Tissue Format. Stem Cell Rep. 2020;15: 983–998. 570
doi:10.1016/j.stemcr.2020.09.002 571
21. Lauschke K, Volpini L, Liu Y, Vinggaard AM, Hall VJ. A Comparative Assessment of Marker Expression 572
Between Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells and the Developing Pig 573
Heart. Stem Cells Dev. 2021;30: 374–385. doi:10.1089/scd.2020.0184 574
22. Yang X, Pabon L, Murry CE. Engineering Adolescence: Maturation of Human Pluripotent Stem Cell-575
derived Cardiomyocytes. Circ Res. 2014;114: 511–523. doi:10.1161/CIRCRESAHA.114.300558 576
23. Yoshida Y, Yamanaka S. Induced Pluripotent Stem Cells 10 Years Later. Circ Res. 2017;120: 1958–1968. 577
doi:10.1161/CIRCRESAHA.117.311080 578
24. Kannan S, Farid M, Lin BL, Miyamoto M, Kwon C. Transcriptomic entropy benchmarks stem cell-derived 579
cardiomyocyte maturation against endogenous tissue at single cell level. PLoS Comput Biol. 2021;17: 580
e1009305. doi:10.1371/journal.pcbi.1009305 581
25. Grancharova T, Gerbin KA, Rosenberg AB, Roco CM, Arakaki JE, DeLizo CM, et al. A comprehensive 582
analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-583
derived cardiomyocytes. Sci Rep. 2021;11: 15845. doi:10.1038/s41598-021-94732-1 584
26. Wang F-S, Chen L-H. Heuristic Optimization. In: Dubitzky W, Wolkenhauer O, Cho K-H, Yokota H, editors. 585
Encyclopedia of Systems Biology. New York, NY: Springer; 2013. pp. 885–885. doi:10.1007/978-1-4419-586
9863-7_411 587
27. Carusi A, Burrage K, Rodríguez B. Bridging experiments, models and simulations: an integrative approach 588
to validation in computational cardiac electrophysiology. Am J Physiol-Heart Circ Physiol. 2012;303: H144–589
H155. doi:10.1152/ajpheart.01151.2011 590
28. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved 591
fluorescence properties. J Biol Chem. 1985;260: 3440–3450. doi:10.1016/S0021-9258(19)83641-4 592
29. Bräuner T, Hülser DF, Strasser RJ. Comparative measurements of membrane potentials with 593
microelectrodes and voltage-sensitive dyes. Biochim Biophys Acta BBA - Biomembr. 1984;771: 208–216. 594
doi:10.1016/0005-2736(84)90535-2 595
30. Sobie EA. Parameter Sensitivity Analysis in Electrophysiological Models Using Multivariable Regression. 596
Biophys J. 2009;96: 1264–1274. doi:10.1016/j.bpj.2008.10.056 597
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
32
31. Krogh-Madsen T, Sobie EA, Christini DJ. Improving cardiomyocyte model fidelity and utility via dynamic 598
electrophysiology protocols and optimization algorithms. J Physiol. 2016;594: 2525–2536. 599
doi:10.1113/JP270618 600
32. Potse M, Krause D, Kroon W, Murzilli R, Muzzarelli S, Regoli F, et al. Patient-specific modelling of cardiac 601
electrophysiology in heart-failure patients. Europace. 2014;16: iv56–iv61. doi:10.1093/europace/euu257 602
33. Lombardo DM, Fenton FH, Narayan SM, Rappel W-J. Comparison of Detailed and Simplified Models of 603
Human Atrial Myocytes to Recapitulate Patient Specific Properties. PLOS Comput Biol. 2016;12: 604
e1005060. doi:10.1371/journal.pcbi.1005060 605
34. Krogh-Madsen T, Jacobson AF, Ortega FA, Christini DJ. Global Optimization of Ventricular Myocyte Model 606
to Multi-Variable Objective Improves Predictions of Drug-Induced Torsades de Pointes. Front Physiol. 607
2017;8. Available: https://www.frontiersin.org/articles/10.3389/fphys.2017.01059 608
35. Clark AP, Wei S, Kalola D, Krogh-Madsen T, Christini DJ. An in silico–in vitro pipeline for drug 609
cardiotoxicity screening identifies ionic pro-arrhythmia mechanisms. Br J Pharmacol. 2022;179: 4829–610
4843. doi:10.1111/bph.15915 611
36. Liepe J, Filippi S, Komorowski M, Stumpf MPH. Maximizing the Information Content of Experiments in 612
Systems Biology. PLOS Comput Biol. 2013;9: e1002888. doi:10.1371/journal.pcbi.1002888 613
37. Chaloner K, Verdinelli I. Bayesian Experimental Design: A Review. Stat Sci. 1995;10: 273–304. 614
doi:10.1214/ss/1177009939 615
38. Ryan EG, Drovandi CC, McGree JM, Pettitt AN. A Review of Modern Computational Algorithms for 616
Bayesian Optimal Design. Int Stat Rev. 2016;84: 128–154. doi:10.1111/insr.12107 617
39. Whittaker DG, Clerx M, Lei CL, Christini DJ, Mirams GR. Calibration of ionic and cellular cardiac 618
electrophysiology models. Wiley Interdiscip Rev Syst Biol Med. 2020;12: e1482. doi:10.1002/wsbm.1482 619
40. Lei CL, Clerx M, Beattie KA, Melgari D, Hancox JC, Gavaghan DJ, et al. Rapid Characterization of hERG 620
Channel Kinetics II: Temperature Dependence. Biophys J. 2019;117: 2455–2470. 621
doi:10.1016/j.bpj.2019.07.030 622
41. Sarkar AX, Sobie EA. Regression Analysis for Constraining Free Parameters in Electrophysiological 623
Models of Cardiac Cells. PLOS Comput Biol. 2010;6: e1000914. doi:10.1371/journal.pcbi.1000914 624
42. Gong JQX, Sobie EA. Population-based mechanistic modeling allows for quantitative predictions of drug 625
responses across cell types. Npj Syst Biol Appl. 2018;4: 1–11. doi:10.1038/s41540-018-0047-2 626
43. Tveito A, Jæger KH, Huebsch N, Charrez B, Edwards AG, Wall S, et al. Inversion and computational 627
maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems. 628
Sci Rep. 2018;8: 17626. doi:10.1038/s41598-018-35858-7 629
44. Morotti S, Liu C, Hegyi B, Ni H, Fogli Iseppe A, Wang L, et al. Quantitative cross-species translators of 630
cardiac myocyte electrophysiology: Model training, experimental validation, and applications. Sci Adv. 631
2021;7: eabg0927. doi:10.1126/sciadv.abg0927 632
45. Kannankeril PJ, Roden DM, Norris KJ, Whalen SP, George AL, Murray KT. Genetic susceptibility to 633
acquired long QT syndrome: Pharmacologic challenge in first-degree relatives. Heart Rhythm. 2005;2: 634
134–140. doi:10.1016/j.hrthm.2004.10.039 635
46. Zequn Z, Yujia W, Dingding Q, Jiangfang L. Off-label use of chloroquine, hydroxychloroquine, azithromycin 636
and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. Eur J 637
Pharmacol. 2021;893: 173813. doi:10.1016/j.ejphar.2020.173813 638
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
33
47. Gutenkunst RN, Waterfall JJ, Casey FP, Brown KS, Myers CR, Sethna JP. Universally Sloppy Parameter 639
Sensitivities in Systems Biology Models. PLoS Comput Biol. 2007;3: e189. 640
doi:10.1371/journal.pcbi.0030189 641
48. Brown KS, Hill CC, Calero GA, Myers CR, Lee KH, Sethna JP, et al. The statistical mechanics of complex 642
signaling networks: nerve growth factor signaling. Phys Biol. 2004;1: 184. doi:10.1088/1478-3967/1/3/006 643
49. Casey FP, Baird D, Feng Q, Gutenkunst RN, Waterfall JJ, Myers CR, et al. Optimal experimental design in 644
an epidermal growth factor receptor signalling and down-regulation model. IET Syst Biol. 2007;1: 190–202. 645
doi:10.1049/iet-syb:20060065 646
50. Forny C, Sube R, Ertel EA. Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a 647
Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates. J Vis Exp JoVE. 2018; 58290. 648
doi:10.3791/58290 649
51. Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, et al. Robust cardiomyocyte differentiation 650
from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci 651
U S A. 2012;109: E1848–E1857. doi:10.1073/pnas.1200250109 652
52. Greenberg MJ, Daily NJ, Wang A, Conway MK, Wakatsuki T. Genetic and Tissue Engineering Approaches 653
to Modeling the Mechanics of Human Heart Failure for Drug Discovery. Front Cardiovasc Med. 2018;5. 654
Available: https://www.frontiersin.org/articles/10.3389/fcvm.2018.00120 655
656
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 8, 2024. ; https://doi.org/10.1101/2024.01.07.574577doi: bioRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.